This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (173) Teleoncology (21) Medication Adherence (88) Pharmacology and Pharmaceutics (69) Cancer Self-Management (55) Chemotherapy and Side Effects Management (60)

Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30090, first published .
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Authors of this article:

Carole Bandiera1, 2, 3 Author Orcid Image ;   Evelina Cardoso4 Author Orcid Image ;   Isabella Locatelli3 Author Orcid Image ;   Antonia Digklia5 Author Orcid Image ;   Khalil Zaman5 Author Orcid Image ;   Antonella Diciolla5 Author Orcid Image ;   Valérie Cristina5 Author Orcid Image ;   Athina Stravodimou5 Author Orcid Image ;   Aedo Lopez Veronica5 Author Orcid Image ;   Ana Dolcan5 Author Orcid Image ;   Apostolos Sarivalasis5 Author Orcid Image ;   Aikaterini Liapi5 Author Orcid Image ;   Hasna Bouchaab5 Author Orcid Image ;   Angela Orcurto5 Author Orcid Image ;   Jennifer Dotta-Celio3 Author Orcid Image ;   Solange Peters5 Author Orcid Image ;   Laurent Decosterd6 Author Orcid Image ;   Nicolas Widmer2, 6, 7, 8 Author Orcid Image ;   Dorothea Wagner5 Author Orcid Image ;   Chantal Csajka2, 4, 7 Author Orcid Image ;   Marie Paule Schneider1, 2 Author Orcid Image
Article Authors Cited by (11) Tweetations (2) Metrics

Journals

  1. Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A, Dolcan A, Sarivalasis A, Zurcher J, Aedo-Lopez V, Dotta-Celio J, Peters S, Guidi M, Wagner A, Csajka C, Schneider M. Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study. Cancers 2023;15(1):316 View
  2. Bandiera C, Pasquier J, Locatelli I, Niquille A, Wuerzner G, Dotta-Celio J, Hachfeld A, Wandeler G, Wagner A, Csajka C, Zanchi A, Cavassini M, Schneider M. Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis. Patient Preference and Adherence 2022;Volume 16:2313 View
  3. Pasquier J, Schneider M, Locatelli I. Estimation of adherence to medication treatment in presence of censoring. British Journal of Clinical Pharmacology 2023;89(7):1928 View
  4. Papus M, Dima A, Viprey M, Schott A, Schneider M, Novais T. Motivational interviewing to support medication adherence in adults with chronic conditions: Systematic review of randomized controlled trials. Patient Education and Counseling 2022;105(11):3186 View
  5. Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher J, Chtioui H, Locatelli I, Decosterd L, Darnaud L, Blanchet B, Alexandre J, Wagner A, Zaman K, Schneider M, Guidi M, Csajka C. Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics 2022;14(7):1317 View
  6. Bandiera C, Skrabal Ross X, Cardoso E, Wagner D, Csajka C, Olver I, Patterson P, Suppiah V, Gunn K, Schneider M. Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland. Supportive Care in Cancer 2022;30(5):3655 View
  7. Engel-Nitz N, Johnson M, Johnson M, Cha-Silva A, Kurosky S, Liu X. Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient Preference and Adherence 2023;Volume 17:1049 View
  8. Bandiera C, Pasquier J, Locatelli I, Schneider M. Using a Semiautomated Procedure (CleanADHdata.R Script) to Clean Electronic Adherence Monitoring Data: Tutorial. JMIR Formative Research 2024;8:e51013 View
  9. Ravix A, Bandiera C, Cardoso E, Lata-Pedreira A, Chtioui H, Decosterd L, Wagner A, Schneider M, Csajka C, Guidi M. Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers 2024;16(12):2193 View
  10. Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A, Stravodimou A, Cristina V, Aedo-Lopez V, Dolcan A, Sarivalasis A, Bouchaab H, Pasquier J, Dotta-Celio J, Peters S, Wagner D, Csajka C, Schneider M, Aoun M. A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial. PLOS ONE 2024;19(6):e0304573 View
  11. Panetta J, Selvo N, Mater D, Stewart C. Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors. Pharmaceutics 2024;16(12):1528 View